我要投票 华佗在中草药行业中的票数:332
· 外 推 电 报 ·
2025-02-05 18:36:49 星期三

【华佗是哪个国家的品牌?】

华佗是什么牌子?「华佗」是 华佗国药股份有限公司 旗下著名品牌。该品牌发源于安徽,由创始人李宏良在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

安徽华佗国药股份有限公司位于三朝古都,华佗故里,中国历史文化名城,全国四大药都之首—安徽省亳州市。安徽华佗国药股份有限公司已有50多年建厂历史,设计规模及生产能力居安徽前列,在全国也位列前茅;2001年又斥资上亿元,由省医药设计院,参照中外合资先进企业的优点和特色,经科学规划、精心设计、高标准建设、全面实施国家医药GMP工程,并于2002年12月8日一次性通过国家GMP认证,是国内第一批通过GMP认证的企业之一。

致力于发展传统的中医药文化,倡导安全用药,安心用药,秉承“用良心制好药”的理念,华佗国药厂自始就以质量控制为第一要务,厂内配有全进口日本岛津公司高效液相仪、气相色谱仪、薄层扫描仪、紫光分析仪等检测设备,堪称高起点,高标准的现代化中成药制造企业和中药材加工基地。厂内现有国内领先的全自动生产灌装线、自动颗粒包装机、自动胶囊填充机、自动铝塑包装机、全自动高效包衣机等现代化设备均完全符合国家GMP标准。并配有空压冷冻系统、净化系统、电视监控系统、数字化管理等一系列先进管理系统;为了进一步的提高中药现代化的进程,我们成立了安徽华佗现代中药研发中心,致力于中国中药现代化的研究与开发。

安徽华佗国药股份有限公司,目前具有年加工中药材5600吨的生产能力,产品有片剂、丸剂、胶囊剂、颗粒剂、单味药颗粒、中药饮片六大剂类型,60多个品种,年产值可达5.6亿元,产品大部分出口,畅销亚、欧、美三十多个国家和地区。在不久的将来,安徽华佗国药股份有限公司将成为中国最大的中成药生产企业和中药材加工基地。

在华佗国药厂的发展历史上,曾受到诸多中央和省市领导人的关心,国务院总理温家宝、副总理回良玉及安徽省历届主要党政领导人曾亲自前往华佗国药厂视察。

安徽华佗国药股份有限公司始终坚持“质量第一,诚信为本,用良心制好药”的经营理念,确保人民安全用药,保障人民身体健康,促进医药经济发展。竭诚欢迎海内外客商来厂洽谈业务,进行经贸合作。

英文翻译:Anhui Huatuo State Pharmaceutical Co., Ltd. is located in Bozhou City, Anhui Province, the capital of three dynasties, the hometown of Huatuo, the famous historical and cultural city of China and the first of the four major pharmaceutical capitals in China. Anhui Huatuo State Pharmaceutical Co., Ltd. has a history of more than 50 years. Its design scale and production capacity rank the top in Anhui Province, and it ranks the top in the country. In 2001, it also spent more than 100 million yuan. With reference to the advantages and characteristics of advanced Sino foreign joint ventures, the Provincial Pharmaceutical Design Institute carried out the national pharmaceutical GMP project through scientific planning, careful design, high standard construction and comprehensive implementation One time through the national GMP certification, is the first batch of domestic enterprises through GMP certification. Committed to the development of traditional Chinese medicine culture, advocating safe drug use, reassuring drug use, and adhering to the concept of "making good medicine with conscience", huatuoguo pharmaceutical factory has been focusing on quality control since the beginning. The factory is equipped with imported high-performance liquid chromatography, gas chromatograph, thin-layer scanner, violet light analyzer and other testing equipment of Shimadzu company of Japan, which can be regarded as a high starting point and a high standard of modernization Pharmaceutical manufacturing enterprises and traditional Chinese medicine processing bases. In the factory, the domestic leading full-automatic production filling line, automatic particle packaging machine, automatic capsule filling machine, automatic aluminum plastic packaging machine, automatic high-efficiency coating machine and other modern equipment are all in full compliance with the national GMP standards. In order to further improve the modernization process of traditional Chinese medicine, we have established Anhui Huatuo modern Chinese medicine research and development center, which is dedicated to the research and development of the modernization of traditional Chinese medicine. Anhui Huatuo State Pharmaceutical Co., Ltd. has an annual production capacity of processing 5600 tons of Chinese herbal medicines. Its products include six types of tablets, pills, capsules, granules, single drug granules and Chinese herbal pieces, with more than 60 varieties. Its annual output value can reach 560 million yuan. Most of its products are exported and sold well in more than 30 countries and regions in Asia, Europe and the United States. In the near future, Anhui Huatuo Guoyao Co., Ltd. will become the largest Chinese patent medicine manufacturer and Chinese herbal medicine processing base in China. In the development history of Huatuo state pharmaceutical factory, it has been concerned by many central and provincial leaders. Premier Wen Jiabao of the State Council, Vice Premier Hui Liangyu and major party and government leaders of Anhui Province have personally visited Huatuo state pharmaceutical factory. Anhui Huatuo State Pharmaceutical Co., Ltd. always adheres to the business philosophy of "quality first, integrity-based, making good medicine with conscience", so as to ensure people's safe drug use, ensure people's health and promote the development of medical economy. We sincerely welcome customers from home and abroad to come to our factory to discuss business and carry out economic and trade cooperation.

本文链接: https://www.waitui.com/brand/e16df2ef3.html 联系电话:0551-4669444

千城特选小程序码

7×24h 快讯

慈星股份:终止筹划购买武汉敏声控股权并配套募资事项,股票明起复牌

36氪获悉,慈星股份公告,公司因筹划发行股份及支付现金购买武汉敏声新技术有限公司控股权并募集配套资金事项,公司股票自2025年1月15日开市时起开始停牌。经交易相关方商讨研究决定终止筹划本次交易事项,公司股票将于2025年2月6日(星期四)开市起复牌。 截至公告日,交易各方未就本次交易具体方案、交易条件达成最终实质性协议。

37分钟前

汇丰控股:昨日耗资约1.76亿港元回购219.76万股公司股份

36氪获悉,汇丰控股公告,公司于2月4日耗资约1.76亿港元回购219.76万股公司股份,每股回购价格79.6港元-80.45港元。

37分钟前

印尼网约车巨头GoTo否认与Grab合并传闻

印尼网约车巨头GoTo当地时间2月4日提交文件,否认同竞争对手Grab的合并传闻。该公司称,“除实施股票回购外,未来12个月内没有任何重大行动计划”。此前有市场消息称,Grab与GoTo最近几周加快协商,认为今年是达成交易的有利时机。两家公司上市后均逐渐朝向取得盈利迈进,但竞争激烈导致价格无法调涨,同时挤压利润空间。据报道,过去几年双方一直在断断续续地协商,合并障碍包括双方之间的分歧,以及两家公司在印尼、新加坡等市场主导地位可能带来的反垄断问题。(界面)

37分钟前

众鑫股份:泰国工厂一车间正式投产,预计2025年完成产量3万吨以上

36氪获悉,众鑫股份公告,公司泰国工厂一车间已顺利安装完毕,并于2025年1月8号开始调试设备并试机生产,2月1日顺利完成试机并正式投产。同时,二车间开始安装设备。公司预计2025年完成产量3万吨以上,2026年完成产量5万吨。此外,公司将根据国际市场的变化情况,决策是否对泰国工厂实施扩产计划。本次试机成功为公司拓展海外业务打下了基础,也验证了新装备的先进性,为今后的装备研发与升级提供了宝贵经验。

37分钟前

杭州银行:2024年净利润169.83亿元,同比增长18.08%

36氪获悉, 杭州银行发布业绩快报,2024年度实现营业收入383.81亿元,同比增长9.61%;归属于上市公司股东的净利润169.83亿元,同比增长18.08%。截至2024年末,公司总资产21125.91亿元,较上年末增长14.73%;贷款总额9374.99亿元,较上年末增长16.16%;存款总额12725.51亿元,较上年末增长21.74%。

37分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询